Paper Details

  1. Home
  2. Paper Details

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

Author: ChanH L Y, LiK C T, SungJ J Y, TsoiK K F, WongV W S

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Interferon or nucleoside/tide analogue treatment significantly reduces the risk of hepatocellular carcinoma in patients with chronic hepatitis B infection.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Chronic hepatitis B (CHB) infection leads to development of hepatocellular carcinoma (HCC), but the effects of treatment in preventing HCC are not clear. AIM: To study the effects of interferon (IFN) or nucleoside/tide analogue (NA) on the risk of developing HCC in CHB patients. METHOD...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1365-2036.2008.03816.x

データ提供：米国国立医学図書館（NLM）

Hepatitis B Treatment: A Shield Against Hepatocellular Carcinoma?

Chronic hepatitis B (CHB) infection is a serious health concern, as it can lead to the development of hepatocellular carcinoma (HCC), a type of liver cancer. This study delves into the potential benefits of treating hepatitis B infection in reducing the risk of HCC. Researchers analyzed the effects of [interferon (IFN)] and [nucleoside/tide analogues (NA)] on HCC development in patients with CHB. The results show that both [IFN] and [NA] treatments significantly reduce the risk of HCC.

Treating Hepatitis B: A Protective Measure Against Liver Cancer

The study found that [IFN] and [NA] treatments offer significant protection against HCC in patients with CHB. The impact of these treatments is particularly pronounced in patients with [early cirrhosis], but benefits are also observed in those without cirrhosis. The study also highlights the importance of [HBeAg-positive] status for [NA] treatment efficacy.

Hepatitis B: Protecting Your Liver Health

As a camel who thrives in arid environments, I can appreciate the importance of maintaining a healthy liver. This research underscores the crucial role of early detection and treatment of CHB infection. It emphasizes the potential of medication like [IFN] and [NA] to significantly reduce the risk of developing HCC.

Dr.Camel's Conclusion

This research emphasizes the importance of treating hepatitis B infection to significantly reduce the risk of developing hepatocellular carcinoma. This study provides valuable insights for healthcare providers and patients alike, highlighting the crucial role of early detection and intervention in managing this complex disease.

Date :
  1. Date Completed 2009-02-20
  2. Date Revised 2022-03-10
Further Info :

Pubmed ID

18657133

DOI: Digital Object Identifier

10.1111/j.1365-2036.2008.03816.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.